Safety, Tolerability and Efficacy of TV-1106 in Adults With Growth Hormone Deficiency

- Growth Hormone Deficiency
- Completed

Study Title: Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Teva Identifier: TV1106-GHD-201 | 2012-004975-37

ClinicalTrials.gov Identifier: NCT01811576

Study Status: Completed

Trial Condition(s): Growth Hormone Deficiency

Interventions: Drug: TV-1106 | Drug: Recombinant human growth hormone

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 23 Years to 65 Years

Trial Duration: March 31, 2013 - August 5, 2013

Phase: Phase 2

Study Type

Interventional